The development of COVID-19 vaccine in Asian countries is on track.

Currently, about 6 companies in South Korea, 4 in Japan, 3 in Taiwan, 2 in Thailand and 1 in Singapore are developing their own COVID-19 vaccine. All have just entered clinical trials or are preparing for large-scale clinical trials. Chinese vaccines whose clinical data are unknown were excluded.

Specifically, Daiichi Sankyo, Shionogi, KMB, AnGes MG in Japan, Medigen, United Biomedical , Adimmune in Taiwan took the lead. Chulalongkorn University and Mahidol University are developing in Thailand. In Singapore, Duke-Nus Medical School is also working with Biotech in the U.S. to conduct research and development. Korea is dom